Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker
The most common cause of heart failure in the canine population is myxomatous mitral valve disease, sometimes complicated by chronic kidney disease. Many studies have been done on the use of symmetric dimethylarginine as biomarker of renal impairment in dogs affected by chronic kidney disease, few s...
Main Authors: | Alice Savarese, Monica Probo, Chiara Locatelli, Sergio Aurelio Zanzani, Alessia Libera Gazzonis, Melissa Papa, Paola Giuseppina Brambilla |
---|---|
Format: | Article |
Language: | English |
Published: |
Tripoli University
2018-08-01
|
Series: | Open Veterinary Journal |
Subjects: | |
Online Access: | https://www.openveterinaryjournal.com/OVJ-2018-02-047%20A.%20Savarese%20et%20al.pdf |
Similar Items
-
Mitral annulus dynamics in myxomatous mitral valve disease
by: Maria-Magdalena Gurzun, et al.
Published: (2021-03-01) -
Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
by: Carlotta Valente, et al.
Published: (2021-09-01) -
Evaluation of the corrected QT interval with Bazett’s Method in Cavalier King Charles Spaniel dogs with myxomatous mitral valve disease
by: Hande Sağoğlu, et al.
Published: (2023-03-01) -
Pro-Inflammatory and Immunological Profile of Dogs with Myxomatous Mitral Valve Disease
by: Diego Piantedosi, et al.
Published: (2022-06-01) -
Myxomatous Mitral Valve Disease with Mitral Valve Prolapse and Mitral Annular Disjunction: Clinical and Functional Significance of the Coincidence
by: Nina C. Wunderlich, et al.
Published: (2021-01-01)